Patents Assigned to Alkermes Controlled Therapeutics Inc. II
  • Patent number: 7118763
    Abstract: Sustained-release microparticle composition. The microparticle composition can be formulated to provide multi-phasic release. In one aspect, the composition includes microparticles having more than one rate of release. In another aspect, the composition includes microparticles that exhibit diffusional release and microparticles that exhibit biodegradation release.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: October 10, 2006
    Assignees: Alkermes Controlled Therapeutics, Inc. II, Janssen Pharmaceutica
    Inventors: Jean Mesens, Michael E. Rickey, Thomas J. Atkins
  • Publication number: 20060182810
    Abstract: Sustained-release microparticle composition. The microparticle composition can be formulated to provide multi-phasic release. In one aspect, the composition includes microparticles having more than one rate of release. In another aspect, the composition includes microparticles that exhibit diffusional release and microparticles that exhibit biodegradation release.
    Type: Application
    Filed: March 2, 2006
    Publication date: August 17, 2006
    Applicants: Janssen Pharmaceutica, N.V., Alkermes Controlled Therapeutics Inc. II
    Inventors: Jean Mesens, Michael Rickey, Thomas Atkins
  • Patent number: 7074883
    Abstract: Copolymers of lactide and glycolide with high glycolide content. The average glycolate block length is less then about 3, which allows the copolymer to be soluble in slightly polar solvents such as methylene chloride.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: July 11, 2006
    Assignee: Alkermes Controlled Therapeutics, Inc. II
    Inventor: Chiem V. Pham
  • Publication number: 20060099271
    Abstract: Methods for preparing microparticles having reduced residual solvent levels. Microparticles are contacted with a non-aqueous washing system to reduce the level of residual solvent in the microparticles. Preferred non-aqueous washing systems include 100% ethanol and a blend of ethanol and heptane. A solvent blend of a hardening solvent and a washing solvent can be used to harden and wash microparticles in a single step, thereby eliminating the need for a post-hardening wash step.
    Type: Application
    Filed: December 21, 2005
    Publication date: May 11, 2006
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Michael Rickey, J. Michael Ramstack, Rajesh Kumar
  • Publication number: 20050276859
    Abstract: A method for preparing biodegradable, biocompatible microparticles. A first phase is prepared that includes a biodegradable, biocompatible polymer, an active agent, and a solvent. A second phase is prepared. The first and second phases are combined to form an emulsion in which the first phase is discontinuous and the second phase is continuous. The discontinuous first phase is separated from the continuous second phase. The residual level of solvent in the discontinuous first phase is reduced to less than about 2% by weight.
    Type: Application
    Filed: May 16, 2005
    Publication date: December 15, 2005
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Michael Rickey, J. Ramstack, Danny Lewis
  • Publication number: 20050266091
    Abstract: Apparatus and method for preparing microparticles using in-line solvent extraction. An emulsion is formed by combining two phases in a static mixer. The emulsion is combined with an extraction liquid in a blending static mixer. The outflow of the blending static mixer is combined with additional extraction liquid. The additional extraction liquid and the outflow of the blending static mixer can be combined in a vessel, or through the use of a static mixer manifold that includes a plurality of static mixers.
    Type: Application
    Filed: June 22, 2005
    Publication date: December 1, 2005
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Shawn Lyons, Steven Wright
  • Publication number: 20050196457
    Abstract: Apparatus and method for preparing microparticles. An emulsion is formed by combining two phases in a static mixing assembly. The static mixing assembly preferably includes a preblending static mixer and a manifold. The emulsion flows out of the static mixing assembly into a quench liquid whereby droplets of the emulsion form microparticles. The residence time of the emulsion in the static mixing assembly is controlled to obtain a predetermined particle size distribution of the resulting microparticles.
    Type: Application
    Filed: January 26, 2005
    Publication date: September 8, 2005
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Shawn Lyons, Steven Wright
  • Patent number: 6939033
    Abstract: Apparatus and method for preparing microparticles using in-line solvent extraction. An emulsion is formed by combining two phases in a static mixer. The emulsion is combined with an extraction liquid in a blending static mixer. The outflow of the blending static mixer is combined with additional extraction liquid. The additional extraction liquid and the outflow of the blending static mixer can be combined in a vessel, or through the use of a static mixer manifold that includes a plurality of static mixers.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: September 6, 2005
    Assignee: Alkermes Controlled Therapeutics, Inc. II
    Inventors: Shawn L. Lyons, Steven G. Wright
  • Patent number: 6884372
    Abstract: Method and apparatus for preparing microparticles using liquid-liquid extraction. A first phase and a second phase are combined to form an emulsion. A portion of the second phase is separated from the emulsion (solvent rich), and the solvent is extracted from the separated second phase, which is then returned (solvent poor) to the emulsion. This process of separation of a solvent rich phase, extraction of solvent, and return of a solvent poor phase, is carried out until a selected level of solvent in the emulsion is achieved. Alternatively, the separated solvent rich phase is not returned to the emulsion, but replaced with another solution, such as an aqueous solution, that is free from solvent. The solvent is preferably extracted into an extraction liquid that functions as a “solvent sink” for the solvent.
    Type: Grant
    Filed: April 12, 2004
    Date of Patent: April 26, 2005
    Assignee: Alkermes Controlled Therapeutics, Inc. II
    Inventor: J. Michael Ramstack
  • Publication number: 20050079224
    Abstract: Methods for preparing microparticles having reduced residual solvent levels. Microparticles are contacted with a non-aqueous washing system to reduce the level of residual solvent in the microparticles. Preferred non-aqueous washing systems include 100% ethanol and a blend of ethanol and heptane. A solvent blend of a hardening solvent and a washing solvent can be used to harden and wash microparticles in a single step, thereby eliminating the need for a post-hardening wash step.
    Type: Application
    Filed: October 4, 2004
    Publication date: April 14, 2005
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Michael Rickey, J. Ramstack, Rajesh Kumar
  • Patent number: 6861016
    Abstract: Apparatus and method for preparing microparticles. An emulsion is formed by combining two phases in a static mixing assembly. The static mixing assembly preferably includes a preblending static mixer and a manifold. The emulsion flows out of the static mixing assembly into a quench liquid whereby droplets of the emulsion form microparticles. The residence time of the emulsion in the static mixing assembly is controlled to obtain a predetermined particle size distribution of the resulting microparticles.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: March 1, 2005
    Assignee: Alkermes Controlled Therapeutics Inc. II
    Inventors: Shawn L. Lyons, Steven G. Wright
  • Publication number: 20050025828
    Abstract: Sustained-release microparticle composition. The microparticle composition can be formulated to provide multi-phasic release. In one aspect, the composition includes microparticles having more than one rate of release. In another aspect, the composition includes microparticles that exhibit diffusional release and microparticles that exhibit biodegradation release.
    Type: Application
    Filed: August 18, 2004
    Publication date: February 3, 2005
    Applicants: Alkermes Controlled Therapeutics Inc. II, Janssen Pharmaceutica
    Inventors: Jean Mesens, Michael Rickey, Thomas Atkins
  • Publication number: 20050020734
    Abstract: The present invention relates to crosslinked polymers, synthesized through ring-opening polymerization of ethylenically unsaturated epoxides, in combination with ?-hydroxy acids using a hydrophilic macroinitiator, such as poly(ethylene glycol), to form substituted copolymers having ethylenically unsaturated functionality randomly distributed along the polyester polymer backbone. That copolymer is subsequently crosslinked to form a hydrogel network. More particularly, the present invention relates to the synthesis of biodegradable poly(?-hydroxy acid-co-glycidyl methacrylate)-block-poly(ethylene glycol)-block-poly(?-hydroxy acid-co-glycidyl methacrylate) copolymers, which are subsequently crosslinked to form hydrogel networks. The invention also relates to the use of these hydrogel networks in various applications, in particular, for the controlled release of drugs and proteins.
    Type: Application
    Filed: August 23, 2004
    Publication date: January 27, 2005
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Firouz Asgarzadeh, Henry Costantino
  • Patent number: 6830737
    Abstract: Method and apparatus for preparing microparticles using liquid-liquid extraction. A first phase and a second phase are combined to form an emulsion. A portion of the second phase is separated from the emulsion (solvent rich), and the solvent is extracted from the separated second phase, which is then returned (solvent poor) to the emulsion. This process of separation of a solvent rich phase, extraction of solvent, and return of a solvent poor phase, is carried out until a selected level of solvent in the emulsion is achieved. Alternatively, the separated solvent rich phase is not returned to the emulsion, but replaced with another solution, such as an aqueous solution, that is free from solvent. The solvent is preferably extracted into an extraction liquid that functions as a “solvent sink” for the solvent.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: December 14, 2004
    Assignee: Alkermes Controlled Therapeutics Inc. II
    Inventor: J. Michael Ramstack
  • Patent number: 6824822
    Abstract: Methods for preparing microparticles having reduced residual solvent levels. Microparticles are contacted with a non-aqueous washing system to reduce the level of residual solvent in the microparticles. Preferred non-aqueous washing systems include 100% ethanol and a blend of ethanol and heptane. A solvent blend of a hardening solvent and a washing solvent can be used to harden and wash microparticles in a single step, thereby eliminating the need for a post-hardening wash step.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: November 30, 2004
    Assignee: Alkermes Controlled Therapeutics Inc. II
    Inventors: Michael E. Rickey, J. Michael Ramstack, Rajesh Kumar
  • Publication number: 20040197469
    Abstract: Apparatus and method for preparing microparticles. An emulsion is formed by combining two phases in a static mixing assembly. The static mixing assembly preferably includes a preblending static mixer and a manifold. The emulsion flows out of the static mixing assembly into a quench liquid whereby droplets of the emulsion form microparticles. The residence time of the emulsion in the static mixing assembly is controlled to obtain a predetermined particle size distribution of the resulting microparticles.
    Type: Application
    Filed: November 17, 2003
    Publication date: October 7, 2004
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Shawn L. Lyons, Steven G. Wright
  • Publication number: 20040197417
    Abstract: A method for preparing biodegradable, biocompatible microparticles. A first phase is_ prepared that includes a biodegradable, biocompatible polymer, an active agent, and a solvent. A second phase is prepared. The first and second phases are combined to form an emulsion in which the first phase is discontinuous and the second phase is continuous. The discontinuous first phase is separated from the continuous second phase. The residual level of solvent in the discontinuous first phase is reduced to less than about 2% by weight.
    Type: Application
    Filed: July 25, 2003
    Publication date: October 7, 2004
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventors: Michael E. Rickey, J. Michael Ramstack, Danny H. Lewis
  • Patent number: 6800663
    Abstract: The present invention relates to crosslinked polymers, synthesized through ring-opening polymerization of ethylenically unsaturated epoxides, in combination with &agr;-hydroxy acids using a hydrophilic macroinitiator, such as poly(ethylene glycol), to form substituted copolymers having ethylenically unsaturated functionality randomly distributed along the polyester polymer backbone. That copolymer is subsequently crosslinked to form a hydrogel network. More particularly, the present invention relates to the synthesis of biodegradable poly(&agr;-hydroxy acid-co-glycidyl methacrylate)-block-poly(ethylene glycol)-block-poly(&agr;-hydroxy acid-co-glycidyl methacrylate) copolymers, which are subsequently crosslinked to form hydrogel networks. The invention also relates to the use of these hydrogel networks in various applications, in particular, for the controlled release of drugs and proteins.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: October 5, 2004
    Assignee: Alkermes Controlled Therapeutics Inc. II,
    Inventors: Firouz Asgarzadeh, Henry R. Costantino
  • Publication number: 20040191324
    Abstract: Method and apparatus for preparing microparticles using liquid-liquid extraction. A first phase and a second phase are combined to form an emulsion. A portion of the second phase is separated from the emulsion (solvent rich), and the solvent is extracted from the separated second phase, which is then returned (solvent poor) to the emulsion. This process of separation of a solvent rich phase, extraction of solvent, and return of a solvent poor phase, is carried out until a selected level of solvent in the emulsion is achieved. Alternatively, the separated solvent rich phase is not returned to the emulsion, but replaced with another solution, such as an aqueous solution, that is free from solvent. The solvent is preferably extracted into an extraction liquid that functions as a “solvent sink” for the solvent.
    Type: Application
    Filed: April 12, 2004
    Publication date: September 30, 2004
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventor: J. Michael Ramstack
  • Publication number: 20040108609
    Abstract: Copolymers of lactide and glycolide with high glycolide content. The average glycolate block length is less then about 3, which allows the copolymer to be soluble in slightly polar solvents such as methylene chloride.
    Type: Application
    Filed: December 1, 2003
    Publication date: June 10, 2004
    Applicant: Alkermes Controlled Therapeutics Inc. II
    Inventor: Chiem V. Pham